Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Buchner

Showing results (31-40 of 207) with videos related to

Pageof 21
Sort By:
The Prostate|July 3, 2023
The impact of previous inguinal mesh hernioplasty on oncological and patient-reported outcomes following radical prostatectomyThilo Westhofen, Moritz Bensel, Boris Schlenker, et al.
Journal of Geriatric Oncology|June 23, 2020
Safety, efficacy and prognostic impact of immune checkpoint inhibitors in older patients with genitourinary cancersGerald Bastian Schulz, Severin Rodler, Bernadett Szabados, et al.
Sexual Medicine|May 22, 2020
Epidemiology and Treatment Barriers of Patients With Erectile Dysfunction Using an Online Prescription Platform: A Cross-Sectional StudySeverin Rodler, Johannes von Büren, Alexander Buchner, et al.
World Journal of Urology|May 12, 2017
Postoperative upgrading of prostate cancer in men ≥75 years: a propensity score-matched analysisAnnika Herlemann, Alexander Buchner, Alexander Kretschmer, et al.
International Journal of Clinical Pharmacy|November 1, 2021
Retrospective evaluation of the impact of non-oncologic chronic drug therapy on the survival in patients with bladder cancerLisa Haimerl, Dorothea Strobach, Hanna Mannell, et al.
Urologia Internationalis|June 4, 2026
Transition Zone PSA Density Does Not Improve Detection of Clinically Significant Prostate Cancer Over Whole-Gland PSAD: A Volume-Stratified Analysis in 3,958 PatientsNiklas Behnel, Lucas Engelage, Agron Lumiani, et al.
Clinical Genitourinary Cancer|November 8, 2011
Outcome assessment of patients with metastatic renal cell carcinoma under systemic therapy using artificial neural networksAlexander Buchner, Martin Kendlbacher, Philipp Nuhn, et al.
Journal of Clinical Medicine|November 14, 2023
The Characterization of Non-oncologic Chronic Drug Therapy in Bladder Cancer Patients and the Impact on Recurrence-Free and Cancer-Specific Survival: A Prospective StudyDorothea Strobach, Lisa Haimerl, Hanna Mannell, et al.
European Urology|December 31, 2010
Long-term follow-up of bladder cancer patients with disseminated tumour cells in bone marrowMargitta Retz, Jens Rotering, Roman Nawroth, et al.
Urology|June 12, 2010
Downregulation of HNF-1B in renal cell carcinoma is associated with tumor progression and poor prognosisAlexander Buchner, Mirna Castro, Anja Hennig, et al.
Pageof 21

Showing results (31-40 of 207) with videos related to

Sort By:
Pageof 21
The Prostate|July 3, 2023
The impact of previous inguinal mesh hernioplasty on oncological and patient-reported outcomes following radical prostatectomyThilo Westhofen, Moritz Bensel, Boris Schlenker, et al.
Journal of Geriatric Oncology|June 23, 2020
Safety, efficacy and prognostic impact of immune checkpoint inhibitors in older patients with genitourinary cancersGerald Bastian Schulz, Severin Rodler, Bernadett Szabados, et al.
Sexual Medicine|May 22, 2020
Epidemiology and Treatment Barriers of Patients With Erectile Dysfunction Using an Online Prescription Platform: A Cross-Sectional StudySeverin Rodler, Johannes von Büren, Alexander Buchner, et al.
World Journal of Urology|May 12, 2017
Postoperative upgrading of prostate cancer in men ≥75 years: a propensity score-matched analysisAnnika Herlemann, Alexander Buchner, Alexander Kretschmer, et al.
International Journal of Clinical Pharmacy|November 1, 2021
Retrospective evaluation of the impact of non-oncologic chronic drug therapy on the survival in patients with bladder cancerLisa Haimerl, Dorothea Strobach, Hanna Mannell, et al.
Urologia Internationalis|June 4, 2026
Transition Zone PSA Density Does Not Improve Detection of Clinically Significant Prostate Cancer Over Whole-Gland PSAD: A Volume-Stratified Analysis in 3,958 PatientsNiklas Behnel, Lucas Engelage, Agron Lumiani, et al.
Clinical Genitourinary Cancer|November 8, 2011
Outcome assessment of patients with metastatic renal cell carcinoma under systemic therapy using artificial neural networksAlexander Buchner, Martin Kendlbacher, Philipp Nuhn, et al.
Journal of Clinical Medicine|November 14, 2023
The Characterization of Non-oncologic Chronic Drug Therapy in Bladder Cancer Patients and the Impact on Recurrence-Free and Cancer-Specific Survival: A Prospective StudyDorothea Strobach, Lisa Haimerl, Hanna Mannell, et al.
European Urology|December 31, 2010
Long-term follow-up of bladder cancer patients with disseminated tumour cells in bone marrowMargitta Retz, Jens Rotering, Roman Nawroth, et al.
Urology|June 12, 2010
Downregulation of HNF-1B in renal cell carcinoma is associated with tumor progression and poor prognosisAlexander Buchner, Mirna Castro, Anja Hennig, et al.
Pageof 21